By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported third-quarter revenue growth of 11 percent, with organic sales up 4 percent year over year.

The St. Louis-based chemicals and research products firm reported total revenues of $626 million for the three-month period ended Sept. 30, compared to revenues of $563 million for Q3 2010. The results fell short of Wall Street estimates for revenues of $632.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.